Arş. Gör. Deniz TURAL

Yayın Ağı

Makaleler 21

1. GLASS: Global Lorlatinib for ALK(+) and ROS1(+) Retrospective Study: Real World Data of 123 NSCLC Patients

Peled N., Gillis R., Kilickap S., Froesch P., Orlov S., Filippova E., et al.

JOURNAL OF THORACIC ONCOLOGY , cilt.16, sa.3, 2021 (SCI-Expanded, Scopus)

2. Clinical and pathological characteristics and their effect on survival in elderly patients with gastrointestinal stromal tumors

Mandel N. M., Selcukbiricik F., Kanitez M., Yalcin S., Tural D., Erdamar S., et al.

JOURNAL OF BUON , cilt.21, sa.2, ss.360-365, 2016 (SCI-Expanded, Scopus)

3. Late relapse of testicular cancer: Recurrence after 24 years and treatment with chemotherapy alone

Akar E., Tural D., Arslan D., BAŞSORGUN C. İ., Yildiz O.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , cilt.11, sa.3, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

4. Preoperative versus postoperative chemoradiotherapy in stage T3, N0 rectal cancer

Tural D., Selcukbiricik F., Yildiz O., Elcin O., Erdamar S., Guney S., et al.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , cilt.19, sa.5, ss.889-896, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

5. P95 HER2 fragments and breast cancer outcome

Tural D., Akar E., Mutlu H., KILIÇKAP S.

EXPERT REVIEW OF ANTICANCER THERAPY , cilt.14, sa.9, ss.1089-1096, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

6. Sunitinib for Patients with Metastatic Non-clear Cell Renal Cell Carcinoma: A Multicenter Retrospective Turkish Oncology Group Trial

Yildiz I., Ekenel M., Akman T., Kocar M., UYSAL M., Kanitez M., et al.

ANTICANCER RESEARCH , cilt.34, sa.8, ss.4329-4334, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

7. Severe liver dysfunction and safe use of 5-fluorouracil leucovorin and oxaliplatin in one patient with metastatic colorectal carcinoma

Tural D., Akar E., Ozturk M. A., Yildiz O., Turna H., Serdengecti S.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , cilt.10, sa.3, ss.745-748, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

8. Analysis of PTEN, BRAF and PI3K status for determination of benefit from cetuximab therapy in metastatic colorectal cancer patients refractory to chemotherapy with wild-type KRAS

Tural D., Batur S., Erdamar S., Akar E., Kepil N., Mandel N. M., et al.

TUMOR BIOLOGY , cilt.35, sa.2, ss.1041-1049, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

9. PET-CT changes the management and improves outcome in patients with recurrent colorectal cancer

Tural D., Selcukbiricik F., Sager S., Akar E., Yildiz O., Serdengecti S.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , cilt.10, sa.1, ss.121-126, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

10. Cancer Pain Prevalence and its Management

Arslan D., Koca T., Akar E., Tural D., Ozdogan M.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.15, sa.20, ss.8557-8562, 2014 (SCI-Expanded, Scopus)

11. Herbal Administration and Interaction of Cancer Treatment

Arslan D., Tural D., Akar E.

JOURNAL OF PALLIATIVE MEDICINE , cilt.16, sa.11, ss.1466-1476, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

12. Gastric cancer: A case study in Turkey

Tural D., Selcukbiricik F., Akar E., Serdengecti S., Buyukunal E.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , cilt.9, sa.4, ss.644-648, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

13. The Relation between Pathological Complete Response and Clinical Outcome in Patients with Rectal Cancer

Tural D., Selcukbiricik F., Ozturk M. A., Yildiz O., Turna H., Er-damar S., et al.

HEPATO-GASTROENTEROLOGY , cilt.60, sa.126, ss.1365-1370, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

14. Association KRAS G13D Tumor Mutated Outcome in Patients with Chemotherapy Refractory Metastatic Colorectal Cancer Treated with Cetuximab

Tural D., Selcukbiricik F., Erdamar S., Ozkurt C. U., Yanmaz T., Mandel N. M., et al.

HEPATO-GASTROENTEROLOGY , cilt.60, sa.125, ss.1035-1040, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

15. Male Breast Cancer: 37-Year Data Study at a Single Experience Center in Turkey

Selcukbiricik F., Tural D., Aydogan F., Bese N., Buyukunal E., Serdengecti S.

JOURNAL OF BREAST CANCER , cilt.16, sa.1, ss.60-65, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

16. Gastrointestinal Stromal Tumors in Turkey: Experiences from 3 Centers

Selcukbiricik F., Yalcin S., Tural D., Erdamar S., Demir G., Dogusoy G., et al.

ONKOLOGIE , cilt.36, ss.18-24, 2013 (SCI-Expanded, Scopus)

17. Male breast cancers behave differently in elderly patients

Tural D., Selcukbiricik F., Aydogan F., Bese N., Yetmen O., Ilvan Ş., et al.

Japanese Journal of Clinical Oncology , cilt.43, sa.1, ss.22-27, 2013 (SCI-Expanded, Scopus)

18. A comparison of patient characteristics, prognosis, treatment modalities, and survival according to age group in gastric cancer patients

Tural D., Selcukbiricik F., Serdengecti S., Buyukunal E.

WORLD JOURNAL OF SURGICAL ONCOLOGY , cilt.10, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

19. Extraskeletal Ewing's sarcoma family of tumors in adults: prognostic factors and clinical outcome.

HIZ V. M. M., Tural ., Molinas M. N., Dervisoglu ., Dincbas F ., Koca ., et al.

Jpn J Clin Oncol , cilt.420-6, ss.1093, 2012 (Hakemli Dergi)

20. Primary gastric lymphoma: conservative treatment modality is not inferior to surgery for early-stage disease.

SELCUKBIRICIK F., TURAL D., ELICIN O., BERK S., Ozgüroğlu M., BESE N., et al.

ISRN oncology , cilt.2012, ss.951816, 2012 (Hakemli Dergi)

21. Perineural Invasion Independent Prognostic Factors in Patients with Gastric Cancer Undergoing Curative Resection

Selcukbiricik F., Tural D., Buyukual E., Serdengecti S.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.13, sa.7, ss.3149-3152, 2012 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 5

1. Sunitinib in patients with metastatic non-clear renal cell carcinoma: A multicentric retpospective Turkish Oncology Group (TOG) trial.

Yildiz I., Ekenel M., Altman T., Kocar M., Uysal M., Kanitez M., et al.

50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri)

2. Prognostic significance of the recurrence pattern and risk factors for recurrence in patients with proximal gastric cancer.

Bilici A., Selcukbiricik F., Ustaalioglu B. B. O., Tural D., Seker M., Gumus M., et al.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri) Sürdürülebilir Kalkınma

3. Gastrointestinal stromal tumor of the rectum with scapular metastasis: a case report

HIZ V. M. M., Selcukbiricik, F., Tural ., Ozturk M. A., Dervisoglu ., Sager .

J Med Case Rep, İstanbul, Türkiye, 07 Haziran 2012, cilt.145., ss.1186-1752, (Tam Metin Bildiri)

4. Thromboembolic complications in cancer patients.

Yenidunya G., Turna H., Ozturk M. A., Tural D., Selcukbiricik F., Yildiz O., et al.

48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30, (Özet Bildiri) Sürdürülebilir Kalkınma

5. NOD POZİTİF MEME KANSERLERİNDE PRİMER TÜMÖR VE AKSİLLER METASTAZIN ER, PR VE HER2 EKSPRESYONU AÇISINDAN KARŞILAŞTIRILMASI

ÖZTÜRK M. A., AYDIN Ö., İLVAN Ş., TURNA Z. H., TURAL D., YILDIZ Ö., et al.

4. TIBBİ ONKOLOJİ KONGRESİ, Antalya, Türkiye, 21 - 25 Mart 2012, ss.103, (Özet Bildiri)

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

232

H-İndeks (WoS)

Atıf (Scopus)

268

H-İndeks (Scopus)

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler